Statistical significance for grouped 300mg + 450mg dose groups was met (PE = 68.6%, p<0.0001), allowing testing of individual dose groups. ILI event defined as central laboratory-confirmed RT-PCR+ ...
Completion of dosing for 5,041 subjects in the Phase 2b NAVIGATE clinical trial, indicating significant progress in the development of CD388 for influenza prevention. Publication of preclinical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results